Company intelligence / Profile preview

Ensemble Orthopedics

Austin, Texas, United States

Ownership: Private
Development stage: Other

Overview

Ensemble Orthopedics develops minimally invasive, interpositional surgical implants for joint replacement in the hand and wrist, primarily targeting osteoarthritis. Their first product, Ensemble CMC™, is FDA-cleared and demonstrated in over 700 implantations by April 2024, with clinical outcomes showing pain relief, joint function improvement, and preservation of anatomy compared to conventional procedures[2][4]. The company has trained over 80 surgeons in its technique and reports 150 patients beyond two years post-op, with over 40 bilateral cases[4].

Therapeutic areas: Rheumatology
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Ensemble Orthopedics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ensemble Orthopedics.

Explore the full profile